Top-News

IntelliCell BioSciences News

Aktie
WKN:  A1JG9X ISIN:  US45825A1051 US-Symbol:  SVFC
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
40,97 Mio.
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 08.07.2013

IntelliCell BioSciences News

10.05.22 - PR Newswire
SVF Investment Corp. 3 Announces Effectiveness of Registration Statement for Business Combination with Symbotic
SVF Investment Corp. 3 Announces Effectiveness of Registration Statement for Business Combination with Symbotic PR Newswire
22.01.13 - PR Newswire
IntelliCell BioSciences Receives Notice of Allowance for its US Patent for "Ultrasonic Cavitation of Adipose Tissue to Produce Stromal Vascular Fraction Regenerative Cells"
IntelliCell BioSciences Receives Notice of Allowance for its US Patent for "Ultrasonic Cavitation of Adipose Tissue to Produce Stromal Vascular Fraction Regenerative Cells" PR ...
10.12.12 - PR Newswire
IntelliCell BioSciences Announces the Addition of Harry Fisch, MD as Director of Urology
IntelliCell BioSciences Announces the Addition of Harry Fisch, MD as Director of Urology PR Newswire
28.11.12 - PR Newswire
IntelliCell BioSciences Announces Research Agreement with the New Jersey Center for Biomaterials at Rutgers-The State University of New Jersey
IntelliCell BioSciences Announces Research Agreement with the New Jersey Center for Biomaterials at Rutgers-​The State University of New Jersey PR Newswire
26.11.12 - PR Newswire
IntelliCell BioSciences Announces Michael Hershman Joins the IntelliCell BioSciences Board of Directors
IntelliCell BioSciences Announces Michael Hershman Joins the IntelliCell BioSciences Board of Directors PR Newswire
15.11.12 - PR Newswire
IntelliCell BioSciences Issues Corrected Listing For Human Cells, Tissues, and Cellular Based Products
IntelliCell BioSciences Issues Corrected Listing For Human Cells, Tissues, and Cellular Based Products PR Newswire
14.11.12 - PR Newswire
IntelliCell BioSciences Announces It Will Present and Run Workshop at the 10th Annual Commercialization of Regenerative Medicine in London
IntelliCell BioSciences Announces It Will Present and Run Workshop at the 10th Annual Commercialization of Regenerative Medicine in London PR Newswire
09.11.12 - PR Newswire
IntelliCell BioSciences Announces FDA Registration for its Cell Processing Facility
IntelliCell BioSciences Announces FDA Registration for its Cell Processing Facility PR Newswire
08.11.12 - PR Newswire
IntelliCell BioSciences Announces FDA Listing For Human Cells, Tissues, and Cellular Based Products
IntelliCell BioSciences Announces FDA Listing For Human Cells, Tissues, and Cellular Based Products PR Newswire
29.10.12 - PR Newswire
IntelliCell BioSciences Announces Myron Z. Holubiak Joins the IntelliCell BioSciences Board of Directors
IntelliCell BioSciences Announces Myron Z. Holubiak Joins the IntelliCell BioSciences Board of Directors PR Newswire
09.10.12 - PR Newswire
IntelliCell BioSciences Announces the Manufacture of Stromal Vascular Fraction Cells from Non-Living Donated Adipose Tissue
IntelliCell BioSciences Announces the Manufacture of Stromal Vascular Fraction Cells from Non-​Living Donated Adipose Tissue PR Newswire
13.09.12 - PR Newswire
IntelliCell BioSciences Announces Clinical Study For Diabetic Critical Limb Ischemia
IntelliCell BioSciences Announces Clinical Study For Diabetic Critical Limb Ischemia PR Newswire
21.08.12 - PR Newswire
IntelliCell BioSciences Files Patent Application for a New Mechanical Method to Separate Stromal Vascular Fraction from the Blood Vessels in Adipose Tissue
IntelliCell BioSciences Files Patent Application for a New Mechanical Method to Separate Stromal Vascular Fraction from the Blood Vessels in Adipose Tissue PR Newswire
23.07.12 - PR Newswire
IntelliCell BioSciences Files Patent Application for a New Research Technique
IntelliCell BioSciences Files Patent Application for a New Research Technique PR Newswire

Newssuche

Videos

newspaper
07.05.24 +17,87%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »